INTERNATIONAL PATENT: SHANGHAI BLUERAY BIOPHARMA CO., LTD., NIKANG THERAPEUTICS, INC. FILES APPLICATION FOR "TETRACYCLIC DERIVATIVES AS K-RAS G12D INHIBITORS"

GENEVA, June 20 -- SHANGHAI BLUERAY BIOPHARMA CO., LTD. (Building 3, No. 576 Libing RdPudong New Area, Shanghai 201203), NIKANG THERAPEUTICS, INC. (Building E500, 200 Powder Mill RoadWilmington, Delaware 19803) filed a patent application (PCT/CN2023/139081) for "TETRACYCLIC DERIVATIVES AS K-Ras G12D INHIBITORS" on Dec 15, 2023. With publication no. WO/2025/123318, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUN, Yongfeng (c/o Shanghai Blueray Biopharma Co., Ltd.Building 3, No. 576 Libing RdPudong New Area, Shanghai 20...